phrykt

Palomino Laboratories Inc. (PALX): who owns it and who trades it

As of Nov 6, 2026, PALX insiders reported 1 purchase worth $50K in the last 12 months. The largest buyer was Richard Ogawa (Director), with $50K.

Latest filing Nov 6, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, PALX insiders reported $50K of open-market purchases and $0 of sales.

Purchases, 12 months
$50K
1 trades, 1 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Apr 20, 2026
Filed Apr 20, 2026

Purchases and sales by month

$50K$50KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Apr 20, 2026Richard OgawaDirectorPurchase12,500$4.00$50KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Richard OgawaSecretary, Director$50K–Apr 20, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PALX short interest

Low short interest. Less than 0.1% of PALX shares are sold short. Over the last 3 reports the number of shares short went down 91%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 15, 2026, 13 PALX shares were sold short, 0.0% of the shares outstanding, down 95.7% from the report before. At the average daily volume of 1,581 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.00%Aug 31Oct 150.00%

Days to cover

1.0Aug 31Oct 151.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 15, 2026130.00%-96%1,5811.0
Sep 30, 20263050.00%–2,2391.0
Aug 31, 20261480.00%–6,5741.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Palomino Laboratories company events

Palomino Laboratories filed 6 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 6, 2026.

  1. Nov 6, 2026VoteReported shareholder vote results. Filing
  2. Aug 5, 2026DealPursuant to the Share Exchange Agreement, at the closing, the Company acquired the Shares in exchange for 4,472,000 shares of Company Stock and assumed the Stockholders’ existing stock purchase agreements with VLI. The shares of Company Stock issued to the Stockholders are subject to certain… Filing
  3. Jul 16, 2026AgreementPalomino Laboratories Inc., a Delaware corporation, entered into a binding letter of intent (this “ Binding Letter of Intent ”) with Vega Links, Inc., a Delaware corporation engaged in the development and expansion of high-speed interconnect infrastructure critical to the advancement of artificial… Filing
  4. May 5, 2026SharesSold new shares outside a public offering. Filing
  5. Apr 24, 2026AgreementThe information contained in Item 3.02 below relating to the various agreements described therein is incorporated herein by reference. Filing
  6. Apr 9, 2026AnnouncementPalomino Laboratories Inc. changed its principal executive offices and principal mailing address from 12 E. 49th Street, 11th Floor, New York, NY 10017 to 130 Castilian Drive, Suite 102, Goleta, CA 93117. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Palomino Laboratories financials

Questions about Palomino Laboratories Inc. (PALX) stock

Are PALX insiders buying or selling?

In the last 12 months, PALX insiders reported 1 open-market purchase worth $50K and no sales. The latest trade was on Apr 20, 2026. See every trade.

What is the short interest in PALX?

As of Oct 15, 2026, 13 PALX shares were sold short, 0.0% of the shares outstanding, down 95.7% from the report before. At the average daily volume of 1,581 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.